All posts by: Admin

About Admin

Market Update on CPAT-01 & Pharmacokinetic Study

Animal health company CannPal Animal Therapeutics Limited (ASX:CP1) (“CannPal” or “the Company”) is pleased to update the market on the recently completed Pharmacokinetic and Safety study for CPAT-01, the Company’s lead pharmaceutical in development as a pain control for dogs. Key Highlights CannPal has successfully completed Phase 1A of the Pharmacokinetic and Safety Study for CPAT-01 with … Continue reading

June 18, 2018 Latest News, News

CannPal Enters into Manufacturing Agreement with Jaychem Industries Ltd

29th May 2018: Animal health company CannPal Animal Therapeutics Limited (ASX:CP1) (“CannPal” or “the Company”) is pleased to announce that it has entered into a strategic manufacturing agreement with Jaychem Industries Ltd (“Jaychem”). Key Highlights CannPal has entered into a manufacturing agreement with New Zealand based veterinary contract manufacturing organization, Jaychem Industries Ltd Jaychem is … Continue reading

May 18, 2018 Latest News, News

CannPal Successfully Imports Cannabis Oils for Clinical Trial of Lead Drug Candidate

Key Highlights CannPal has been granted export permits by Health Canada for its medical cannabis oil formulations Oils have now arrived in Sydney, Australia and are in transit to a purpose-built research facility for the clinical phase of the Company’s research cGMP accredited licensed producer Aphria Inc (TSE:APH), has provided the clinical trial material for … Continue reading

March 27, 2018 Latest News, News

CannPal Granted SME Status by the European Medicines Agency (EMA)

Key Highlights CannPal has received confirmation of SME (Small and Medium size Enterprises) status,with the European Medicines Agency (EMA)  The European Medicines Agency is the European Union agency responsible for the evaluation and regulation of veterinary medicinal products (VMP’s) in Europe; The SME status allows CannPal a line of communication with the EMA for the … Continue reading

December 18, 2017 Latest News, News

CannPal Granted a Permit to Possess and Supply Cannabis by NSW State Department of Health

Key Highlights CannPal has been granted a permit to possess and supply tetrahydrocannabinol and cannabidiol for the purpose of scientific research by the NSW State Department of Health The permit allows the provision of cannabis to researchers in NSW for the purpose of CannPal’s clinical trials in Q1 CY18 The authorisation has been issued under … Continue reading

November 3, 2017 Latest News, News, Uncategorized

CannPal Advances Research Through Agreement with The University of Queensland

Key Highlights CannPal has entered into a research services agreement with The University of Queensland The University of Queenlands’s TetraQ Research Infrastructure Centre will provide bio-analytical services for CannPal’s pharmacokinetic and safety studies TetraQ will develop and validate a method for quantification of cannabidiol and tetrahydrocannabinol concentration in dog plasma samples Over 48 dogs will … Continue reading

October 31, 2017 Latest News, News